Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
-
Published:2023-09
Issue:9
Volume:24
Page:1029-1041
-
ISSN:1470-2045
-
Container-title:The Lancet Oncology
-
language:en
-
Short-container-title:The Lancet Oncology
Author:
Hurvitz Sara AORCID,
Bardia Aditya,
Quiroga Vanesa,
Park Yeon Hee,
Blancas Isabel,
Alonso-Romero José Luis,
Vasiliev Aleksandr,
Adamchuk Hryhoriy,
Salgado Marcelo,
Yardley Denise A,
Berzoy Oleksandr,
Zamora-Auñón Pilar,
Chan David,
Spera Gonzalo,
Xue Cloris,
Ferreira Erika,
Badovinac Crnjevic Tanja,
Pérez-Moreno Pablo Diego,
López-Valverde Vanesa,
Steinseifer Jutta,
Fernando Tharu M,
Moore Heather M,
Fasching Peter A
Funder
F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献